Refine by
Power Generation Articles & Analysis
31 news found
One of the most exciting aspects of the NIH Research Festival was its focus on next-generation technologies, and Creative Biolabs didn't disappoint in this regard. ...
CD Genomics, a leading provider of genomic services, is proud to announce a groundbreaking advancement in microsatellite development that is set to transform the landscape of genetic research. Leveraging the power of next-generation sequencing (NGS), CD Genomics enables researchers to harness the full potential of microsatellite markers for a wide range of ...
The power lies in the underlying structuring of data” said Mika Newton, CEO of xCures. ...
ByxCures
Agreement strengthens Bayer’s new cell and gene therapy platform further Supports Mammoth’s vision of unlocking the full potential of novel CRISPR systems Mammoth to receive upfront payment of USD 40 million, and potential future milestone payments of more than one billion USD upon successful achievement Bayer AG and Mammoth Biosciences, Inc., which is harnessing the diversity ...
Comprising a team of scientist-founders, experienced biopharma veterans, and talented researchers, Mammoth is developing a robust pipeline of novel CRISPR systems capable of providing permanent cures for genetic conditions, and powering next-generation diagnostic tools to enable decentralized disease detection. ...
Proprietary technologies are being developed to enrich pathogenic DNA / RNA for analysis through harnessing the power of Next-Generation Sequencing platforms and proprietary artificial intelligence-based software analytics with the goal to rapidly identify and detect any foreign pathogens (virus, bacteria, fungus, parasites) without bias through its genome ...
“We’re delighted to welcome Elaine to our growing team, as we realize our mission of bringing forth the next generation of CRISPR-based diagnostics and therapeutics,” said Trevor Martin, co-founder and Chief Executive Officer of Mammoth Biosciences. ...
ImpediMed Limited (ASX.IPD), a medical technology company that uses bioimpedance spectroscopy (BIS) technology to generate powerful data to maximize patient health is pleased to announce an abstract comparing concurrent measures using ImpediMed’s SOZO® Digital Health Platform and dual x-ray absorptiometry (DXA) for assessing in bone mineral content in ...
Lymphatic Research and Biology Publishes Data on PREVENT, the Largest Randomized Trial to Assess Lymphedema Prevention L-Dex Technology Provides a New Standard Approach for Prevention of Cancer-Related Lymphedema ImpediMed Limited (ASX: IPD), a global medical technology company using bioimpedance spectroscopy (BIS) to generate powerful data to ...
Food and Drug Administration (FDA) has granted Emergency Use Authorization (EUA) for its DETECTR BOOST® SARS-CoV-2 Reagent Kit, a first of its kind high-throughput solution that combines the power of CRISPR with laboratory automation for SARS-CoV-2 testing. ...
Mammoth Biosciences, a biotech company building the next generation of CRISPR products to cure and detect disease, today announced its participation in the upcoming 40th Annual J.P. ...
--(BUSINESS WIRE)--Mojo Vision, the Invisible Computing Company, today announced strategic partnerships with leading sports and fitness brands to collaborate on next-generation user experiences that combine augmented reality, wearable technology and personal performance data. ...
Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) and Mammoth Biosciences, a biotech company building the next generation of CRISPR products to cure and detect disease, today announced a new partnership to develop in vivo gene-editing therapies for two genetic diseases using Mammoth’s next-generation CRISPR systems. ...
CRISPR systems for in vivo gene-editing therapeutics Makes key appointment of biotech veteran Gary Loeb as general counsel Mammoth Biosciences, the biotech company leveraging the diversity of life to build the next generation of CRISPR products to cure and detect disease, today announced it has secured $195 million in financing, joining the select ranks of ...
The Riello UPS Multi Sentry MSTs achieve an efficiency of up to 96%, saving 35% of the energy dissipated in a year and providing up to 15% more active power than similar UPS available on the market. The Master MPS guarantees maximum protection and power quality for any type of load, making it easier and more efficient to supply power from ...
Mammoth Biosciences today announced that it has been named by Fierce Medtech as one of 2020’s Fierce 15, designating it as one of the most promising private companies in the industry. This designation comes after a year of immense momentum at the company as it leverages its innovative CRISPR platform in the fight against the COVID-19 pandemic and beyond. As a leader in the development of ...
Many of these patients could benefit greatly from the Second Heart Assist circulatory assist pump, designed to deliver continuous and reliable renal support while maintaining consistent positioning through its aortic stent technology platform. The 2nd generation wireless powered chronic implant in development represents a potentially huge leap ...
"This once again is testing our industry’s resilience, but we believe, over the long run, we are well positioned to outcompete incumbent generators...and to continue growing our market share,” it said. ...
With preparations underway for manufacturing the MIFTEC Z-pinch (ZEBRA) Fusion Medical Isotope Generators, US Nuclear Corp. (OTCBB: UCLE) is one step closer to ending the dire worldwide shortage of medical isotopes. ...
” The investigative report specifically looked at the aftermath of the storm that left residents with “mold-producing wreckage across the island and forcing many to use fume-spewing generators for power.” One doctor, interviewed for the piece that treats patients in a working-class neighborhood, gave her view of how asthma rates have increased ...